Austin Central In The News
Read the latest Austin Central news and stories.
Publication: Targeted Oncology
4/11/2024 - A global phase 3 clinical trial planning to evaluate an mRNA vaccine for the treatment of patients with high-risk melanoma that have already undergone surgery is underway. Jeff Yorio, M.D., medical oncologist and central Texas research leader for Texas Oncology, discussed with Targeted Oncology the unmet needs in this patient group and plans for this phase 3 study.
Publication: KTBC-TV (FOX, Austin)
4/2/2024 - Jeff Yorio, M.D., lead trial investigator at Texas Oncology-Austin Central joined KTBC-TV’s (FOX, Austin) “HealthBeat” segment to discuss the new clinical trial using mRNA technology to prevent melanoma reoccurrence. Dr. Yorio shared more about the status of patient enrollment, why this clinical trial is so unique, and the likelihood of this vaccine going to market within the next few years.
Publication: KVUE-TV (ABC, Austin)
3/28/2024 - Texas Oncology has enrolled patients in a phase 3 clinical trial testing an mRNA vaccine for stage II-IV melanoma that has been surgically resected. Jeff Yorio, M.D., medical oncologist at Texas Oncology–Austin Central and trial investigator, shares with KVUE-TV the goal of the trial and what patients are eligible, why mRNA technology is innovative and exciting in cancer care, and how personalization of cancer treatment helps target patients’ individual cancers.
Publication: Austin American-Statesman
3/25/2024 - Texas Oncology has enrolled patients in an innovative stage 3 clinical trial testing an mRNA vaccine for melanoma treatment. Jeff Yorio, M.D., Texas Oncology-Austin Central, shared how the melanoma vaccine is created, what results are expected and what the trial could mean for the future of melanoma treatment.
Publication: The American Journal of Managed Care
3/12/2024 - The mental health struggle that accompanies a cancer diagnosis is real, and the burden of dealing with so many conflicting emotions falls not only on the patients but also on their caregivers, families, friends, and physicians. Kathryn E. Hudson, M.D., director of survivorship and medical oncologist at Texas Oncology-Austin Central explains the complex picture of emotions patients feel throughout their cancer journey and why mental health support should be a part of all cancer care.
Publication: KTBC-TV (FOX, Austin)
2/8/2024 - Rebecca L. Wiatrek, M.D., FACS, Texas Oncology Surgical Specialists-Austin Central and Round Rock joined KTBC-TV’s (FOX, Austin) “HealthBeat” segment to discuss stomach cancer, in light of country singer Toby Keith’s recent death by this disease. According to the American Cancer Society, stomach cancer accounts for 1.5% of all new cancer cases diagnosed each year in the U.S., making this disease fairly rare, yet one to know the signs and symptoms for.
Publication: Austin Medical Times, Houston Medical Times
2/2/2024 - When it comes to the heart and cancer treatment, balancing the effectiveness of cancer therapies with the preservation of heart function is essential to improving the long-term cardiovascular health of cancer patients. Karen Cohen, M.D.,Texas Oncology–Austin Central and Round Rock and Andrew Jackson, M.D., Texas Oncology–The Woodlands, share how healthcare providers and cancer patients can make informed decisions when it comes to matters of the heart.
Publication: Austin Medical Times, Houston Medical Times
10/1/2023 - Unlocking the genetic “secrets” inside cancer cells is revolutionizing oncology. This advancement in medical science is the foundation of precision medicine, which provides patients with more personalized and targeted treatment, based on understanding the genetic information of a patient’s cancer.
Publication: SurvivorNet
9/27/2023 - PARP inhibitors have dramatically changed the cancer treatment paradigm, especially for ovarian cancer patient, Melinda Fiebig. Melinda joined SurvivorNet to share how PARP treatment really worked for her – and the best part was it didn’t interrupt her day-to-day life.
Publication: Austin American-Statesman
9/3/2023 - In September 2022, Mark Tempelmeyer, 64, received a call that changed his life. After being diagnosed with stage IV prostate cancer, Mark and his wife Helene aimed to "find him the best in Austin," and he was referred to Kyle T. Keyes, M.D., Texas Urology Specialists–Austin and Austin Midtown, and Mike Lattanzi, M.D., Texas Oncology–Austin Central, to treat his cancer. Now that his most recent PSA score registered at a 0.1, Mike and Helene live a full life together with a fresh perspective.